• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ME

ME

23andMe Holding Co.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD0.61

+0.61 (+100.00%)

Company Profile

CEO

Joseph Selsavage

IPO Date

2020-11-23

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.61

Prev. Close

$0.61

Day Low

$0.61

Day High

$0.61

52W Low

$0.48

52W High

$12.76

Market Cap

$0.02B

Volume

29.75M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

29.2%

Avg Negative

1.4%

Avg Neutral

69.5%

News Feed

23andMe: New Therapeutic Pipeline And PGS Product Growth Catalyzed By +$696M In SPAC Funding

Seeking Alpha·7/18/2021·↑ positive

Is 23andMe a Buy at $11?

The Motley Fool·6/29/2021·↑ positive

Can You Count on 23andMe Stock?

The Motley Fool·6/24/2021·↑ positive

Industry Leaders Join 23andMe Board of Directors

GlobeNewsWire·6/21/2021·↑ positive

23andMe CEO on public debut, future of genetic testing

Yahoo Finance·6/19/2021·↑ positive

ME Stock Price Increased 21.2% In Market Debut: Details

Pulse2·6/18/2021·↑ positive

DNA Testing Company 23andMe Makes Nasdaq Debut

Cheddar·6/17/2021·↑ positive

IPO Report: 23andMe shares surge 17% in their trading debut after merger with Richard Branson-backed SPAC

Market Watch·6/17/2021·↑ positive

Genetic testing company 23andMe rises in first trade after Richard Branson SPAC merger

CNBC·6/17/2021·↑ positive

23andMe to go public on NASDAQ under ticker symbol 'Me'

Yahoo Finance·6/17/2021·↑ positive